» Articles » PMID: 10216193

Nanomolar Concentrations of Lead Inhibit Glutamatergic and GABAergic Transmission in Hippocampal Neurons

Overview
Journal Brain Res
Specialty Neurology
Date 1999 Apr 27
PMID 10216193
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate whether lead (Pb2+) affects the tetrodotoxin (TTX)-sensitive release of neurotransmitters, the whole-cell mode of the patch-clamp technique was applied to cultured hippocampal neurons. Pb2+ (>/=10 nM) reversibly blocked the TTX-sensitive release of glutamate and gamma-aminobutyric acid (GABA), as evidenced by the reduction of the amplitude and frequency of glutamate- and GABA-mediated postsynaptic currents (PSCs) evoked by spontaneous neuronal firing. This effect of Pb2+, which occurred 2-3 s after exposure of the neurons to Pb2+-containing external solution, was not related to changes in Na+-channel activity, and was quantified by measurements of changes in the amplitude of PSCs evoked when a 50-micros, 5-V stimulus was applied via a bipolar electrode to a neuron synaptically connected to the neuron under study. With an IC50 of approximately 68 nM, Pb2+ blocked the evoked release of glutamate and GABA. This effect was most likely mediated by Pb2+'s actions on extracellular targets, because there was a very short delay (<3 s) for its onset, and it could be completely reversed by the chelator ethylene diaminetetraacetic acid (EDTA). Given that Pb2+-induced blockade of evoked transmitter release could be reversed by 4-aminopyridine, it is suggested that the effect on release was mediated via the binding of Pb2+ to voltage-gated Ca2+ channels. Thus, it is most likely that the neurotoxic effects of Pb2+ in the mammalian brain involve a decrease of the TTX-sensitive, Ca2+-dependent release of neurotransmitters.

Citing Articles

Assessment of neurotransmitter release in human iPSC-derived neuronal/glial cells: a missing in vitro assay for regulatory developmental neurotoxicity testing.

Cervetto C, Pistollato F, Amato S, Mendoza-de Gyves E, Bal-Price A, Maura G Reprod Toxicol. 2023; 117:108358.

PMID: 36863571 PMC: 10112275. DOI: 10.1016/j.reprotox.2023.108358.


A proteomic study to unveil lead toxicity-induced memory impairments invoked by synaptic dysregulation.

Mohanraj N, Joshi N, Poulose R, Patil R, Santhoshkumar R, Kumar A Toxicol Rep. 2022; 9:1501-1513.

PMID: 36518382 PMC: 9742914. DOI: 10.1016/j.toxrep.2022.07.002.


A Comparative Analysis of Heavy Metal Effects on Medicinal Plants.

Mukherjee S, Chatterjee N, Sircar A, Maikap S, Singh A, Acharyya S Appl Biochem Biotechnol. 2022; 195(4):2483-2518.

PMID: 35488955 DOI: 10.1007/s12010-022-03938-0.


Cognitive Impairment Induced by Lead Exposure during Lifespan: Mechanisms of Lead Neurotoxicity.

Ramirez Ortega D, Gonzalez Esquivel D, Blanco Ayala T, Pineda B, Gomez Manzo S, Marcial Quino J Toxics. 2021; 9(2).

PMID: 33525464 PMC: 7912619. DOI: 10.3390/toxics9020023.


The Neuroprotective Role of Coenzyme Q10 Against Lead Acetate-Induced Neurotoxicity Is Mediated by Antioxidant, Anti-Inflammatory and Anti-Apoptotic Activities.

Yousef A, A Fahad A, Abdel Moneim A, Metwally D, El-Khadragy M, Kassab R Int J Environ Res Public Health. 2019; 16(16).

PMID: 31412628 PMC: 6720293. DOI: 10.3390/ijerph16162895.